药品
抗体
溶血性贫血
免疫系统
自身免疫性溶血性贫血
自身抗体
免疫学
贫血
医学
血清学
免疫复合物
库姆斯试验
溶血
药理学
内科学
出处
期刊:Immunohematology / American Red Cross
[Exeley, Inc.]
日期:2014-01-01
卷期号:30 (2): 44-54
被引量:41
标识
DOI:10.21307/immunohematology-2019-098
摘要
Drug-induced immune hemolytic anemia (DIIHA) is a rare condition that occurs primarily as a result of drug-induced antibodies, either drug-dependent or drug-independent. Drug- dependent antibodies can be detected by testing drug-treated red blood cells (RBCs) or untreated RBCs in the presence of a solution of drug. Drug-independent antibodies react with untreated RBCs (no drug added) and cannot be distinguished from warm autoantibodies. Many changes have occurred during the last 30 years, such as which drugs most commonly cause DIIHA, the optimal testing methods for identifying them, and the theories behind the mechanisms by which they react. This article reviews the major changes in DIIHA since the early 1980s involving the immune complex mechanism, cephalosporins, nonimmunologic protein adsorption, and penicillins. Because serologic results associated with DIIHA can mimic those expected with autoimmune hemolytic anemia or hemolytic transfusion reactions, DIIHA may go undetected in some cases.
科研通智能强力驱动
Strongly Powered by AbleSci AI